Forge Biologics is a US-based gene therapy CDMO delivering innovative manufacturing solutions designed to guide therapies from early development through clinical trials and into commercial production.
Our mission is to enable access to life-changing therapies by helping to bring them from concept to reality. We provide comprehensive AAV manufacturing services, technologies, and infrastructure so gene therapy developers can deliver more therapies to more patients.
As a subsidiary of the Ajinomoto Group, we combine deep AAV manufacturing expertise with the global scale and strength of a company committed to scientific innovation and improving human health.
